Mechanisms at the interface of DNA damage repair and transcription

This project aims to elucidate the mechanisms of transcription-coupled repair and resolution of transcription-replication conflicts at DNA lesions using innovative genomic and proteomic approaches.

Subsidie
€ 1.999.764
2022

Projectdetails

Introduction

Bulky DNA lesions are a major obstacle during gene transcription by RNA polymerase II enzymes (RNAPII). The stalling of RNAPII at DNA lesions triggers a genome-wide transcriptional arrest.

Transcription-Coupled Repair

Transcription-coupled repair (TCR) is a specialized DNA repair pathway that selectively removes DNA lesions from actively transcribed genes to restore transcription. Stalled RNAPII at DNA lesions forms a roadblock for advancing DNA replication forks, resulting in toxic collisions.

Knowledge Gaps

The mechanisms that enable the repair of transcription-blocking DNA lesions, the restoration of transcription after repair, and the resolution of transcription-replication conflicts are poorly understood.

Proposed Approaches

To address these knowledge gaps, I propose to establish a series of innovative approaches aimed at identifying the mechanisms involved in the cellular responses to transcription-blocking DNA damage. We will focus on the functional characterization of known and several promising new TCR factors that we recently identified in combined genome-wide CRISPR and targeted proteomics screens.

Specific Aims

I propose to dissect the role of known and new TCR proteins by:

  1. Applying a genome-wide approach for directly measuring TCR activity in combination with proximity-labelling proteomics and genetic-interaction mapping to define how TCR complexes assemble and operate.
  2. Identifying the mechanisms in transcription restoration by combining advanced genomics methods to map nascent transcripts, monitor RNAPII occupancy, and correlate these with specific chromatin modifications in a genome-wide manner.
  3. Dissecting the mechanisms involved in resolving transcription-replication conflicts by combining functional DNA replication assays with genome-wide approaches to map transcription, R-loops, and DNA replication directionality.

Conclusion

This ERC project will break new ground by offering a detailed understanding of the mechanisms that enable cells to overcome transcriptional roadblocks.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.764
Totale projectbegroting€ 1.999.764

Tijdlijn

Startdatum1-6-2022
Einddatum31-5-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • ACADEMISCH ZIEKENHUIS LEIDENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Molecular mechanisms, functions and applications of RNA-guided DNA transposons

This project aims to enhance understanding of RNA-guided DNA transposons to develop advanced genome editing tools for biotechnology and precision medicine.

€ 1.499.403
ERC Consolid...

Understanding mechanisms of Transcription Factor cooperativity across scales

TFCoop aims to uncover general principles of transcription factor cooperativity in gene regulation through extensive perturbation studies and advanced genomic techniques, enhancing understanding for regenerative medicine.

€ 1.990.221
ERC Consolid...

Deconstruction of complex crosslinking damage

This project aims to elucidate the effects of RNA and protein crosslinking damage on cellular homeostasis using novel model systems, enhancing understanding of quality control mechanisms and implications for cancer therapy.

€ 2.000.000
ERC Starting...

Chromatin re-organization in response to replication stress

This project aims to investigate how stalled replication forks reorganize within the 3-D nuclear space during replication stress to enhance fork stability and chemoresistance in cancer cells.

€ 1.500.000
ERC Consolid...

Decoding subcellular spatial biology with high precision using RNA photocatalysts

This project aims to develop a low-cost, high-precision technology for deciphering RNA interactions, enhancing understanding of RNA networks and uncovering new therapeutic targets for diseases.

€ 1.999.525